Cargando...
Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
PURPOSE: The purpose of our study is to report our experience with the use of certolizumab pegol in patients with refractory non-infectious uveitis. OBSERVATIONS: We present a case series of three patients with non-infectious uveitis, treated with twice-monthly subcutaneous certolizumab pegol. All o...
Guardado en:
| Publicado en: | Am J Ophthalmol Case Rep |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068621/ https://ncbi.nlm.nih.gov/pubmed/32190782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100633 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|